Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement

J Heart Lung Transplant. 2026 Feb;45(2):168-171. doi: 10.1016/j.healun.2025.09.016.
No abstract available

Keywords: Antibody-mediated rejection (AMR); Chronic lung allograft dysfunction (CLAD); Clinical trial endpoints; Lung transplantation; Patient-reported outcomes (PROs); Primary graft dysfunction.

Publication types

  • Practice Guideline